tradingkey.logo
tradingkey.logo
Buscar

NeuroOne Medical Technologies Corp

NMTC
Añadir a la lista de seguimiento
3.000USD
-0.040-1.32%
Cierre 07/01, 16:00ETCotizaciones retrasadas 15 min
25.85MCap. mercado
PérdidaP/E TTM

Más Datos de NeuroOne Medical Technologies Corp Compañía

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

Información de NeuroOne Medical Technologies Corp

Símbolo de cotizaciónNMTC
Nombre de la empresaNeuroOne Medical Technologies Corp
Fecha de salida a bolsaNov 09, 2012
Director ejecutivoRosa (David A)
Número de empleados17
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 09
Dirección7599 Anagram Dr
CiudadEDEN PRAIRIE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55344-7399
Teléfono19524261383
Sitio Webhttps://nmtc1.com/
Símbolo de cotizaciónNMTC
Fecha de salida a bolsaNov 09, 2012
Director ejecutivoRosa (David A)

Ejecutivos de NeuroOne Medical Technologies Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%
Mr. Ronald (Ron) Mcclurg
Mr. Ronald (Ron) Mcclurg
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher R. Volker
Mr. Christopher R. Volker
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Emily Johns
Ms. Emily Johns
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Chris Donovan
Mr. Chris Donovan
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
33.11K
-15.23%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Edward (Ed) Andrle
Mr. Edward (Ed) Andrle
Independent Director
Independent Director
22.32K
+31.31%
Mr. Steve Mertens
Mr. Steve Mertens
Chief Technology Officer
Chief Technology Officer
15.43K
-0.98%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de NeuroOne Medical Technologies Corp?

Los cinco principales accionistas de NeuroOne Medical Technologies Corp son: Mr. David A. (Dave) Rosa

¿Cuántas instituciones poseen acciones de NeuroOne Medical Technologies Corp (NMTC)?

A fecha de 2026Q1, 58 instituciones poseen acciones de NeuroOne Medical Technologies Corp, con un valor de mercado combinado de aproximadamente 2.36M, lo que representa el 28.07% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -230396.00.